Slot System
Featured Buckets
Featured Buckets Admin

David Henry's JCSO podcast, May 2015

Article Type
Changed
Thu, 12/15/2022 - 18:04
Display Headline
David Henry's JCSO podcast, May 2015

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry looks at Original Reports on the treatment of metastatic breast cancer with nab-paclitaxel in the community practice setting; health professionals’ attitudes toward detecting and managing cancer-related anorexia-cachexia syndrome; the factors associated with symptom-related emergency department visits and hospital admissions during ambulatory cancer treatment; and differences in treatment between urban and rural women with hormone receptor-positive early-stage breast cancer. He also discusses a case report on a patient with severe chemotherapy-induced peripheral neuropathy who experienced a significant response to lacosamide, and Community Translations item using blinatumomab for hard-to-treat acute lymphoblastic leukemia.  

References

Author and Disclosure Information

Audio / Podcast
Publications
Topics
Legacy Keywords
blinatumomab, relapsed/ refractory, Philadelphia chromosome-negative, B-cell acute lymphoblastic leukemia,
BCP-ALL, CD19, CD3, dosage-schedule, nab-paclitaxel, metastatic breast cancer, MBC, human epidermal growth factor receptor 2, HER2–negative, anorexia-cachexia syndrome, CACS, non-small-cell lung cancer, NSCLC, symptom distress, quality of life, QoL, side effects, emergency department, ED, hospital admissions, HAs, emergency department visits, EDVs, symptom-related EDVs, sx-EDV/HAs, urban, rural, hormone receptor-positive, breast cancer, lacosamide, anticonvulsant, chemotherapy-induced peripheral neuropathy, CIPN, urothelial carcinoma,
MVAC, methotrexate, vincristine, adriamycin, cisplatin
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry looks at Original Reports on the treatment of metastatic breast cancer with nab-paclitaxel in the community practice setting; health professionals’ attitudes toward detecting and managing cancer-related anorexia-cachexia syndrome; the factors associated with symptom-related emergency department visits and hospital admissions during ambulatory cancer treatment; and differences in treatment between urban and rural women with hormone receptor-positive early-stage breast cancer. He also discusses a case report on a patient with severe chemotherapy-induced peripheral neuropathy who experienced a significant response to lacosamide, and Community Translations item using blinatumomab for hard-to-treat acute lymphoblastic leukemia.  

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry looks at Original Reports on the treatment of metastatic breast cancer with nab-paclitaxel in the community practice setting; health professionals’ attitudes toward detecting and managing cancer-related anorexia-cachexia syndrome; the factors associated with symptom-related emergency department visits and hospital admissions during ambulatory cancer treatment; and differences in treatment between urban and rural women with hormone receptor-positive early-stage breast cancer. He also discusses a case report on a patient with severe chemotherapy-induced peripheral neuropathy who experienced a significant response to lacosamide, and Community Translations item using blinatumomab for hard-to-treat acute lymphoblastic leukemia.  

References

References

Publications
Publications
Topics
Article Type
Display Headline
David Henry's JCSO podcast, May 2015
Display Headline
David Henry's JCSO podcast, May 2015
Legacy Keywords
blinatumomab, relapsed/ refractory, Philadelphia chromosome-negative, B-cell acute lymphoblastic leukemia,
BCP-ALL, CD19, CD3, dosage-schedule, nab-paclitaxel, metastatic breast cancer, MBC, human epidermal growth factor receptor 2, HER2–negative, anorexia-cachexia syndrome, CACS, non-small-cell lung cancer, NSCLC, symptom distress, quality of life, QoL, side effects, emergency department, ED, hospital admissions, HAs, emergency department visits, EDVs, symptom-related EDVs, sx-EDV/HAs, urban, rural, hormone receptor-positive, breast cancer, lacosamide, anticonvulsant, chemotherapy-induced peripheral neuropathy, CIPN, urothelial carcinoma,
MVAC, methotrexate, vincristine, adriamycin, cisplatin
Legacy Keywords
blinatumomab, relapsed/ refractory, Philadelphia chromosome-negative, B-cell acute lymphoblastic leukemia,
BCP-ALL, CD19, CD3, dosage-schedule, nab-paclitaxel, metastatic breast cancer, MBC, human epidermal growth factor receptor 2, HER2–negative, anorexia-cachexia syndrome, CACS, non-small-cell lung cancer, NSCLC, symptom distress, quality of life, QoL, side effects, emergency department, ED, hospital admissions, HAs, emergency department visits, EDVs, symptom-related EDVs, sx-EDV/HAs, urban, rural, hormone receptor-positive, breast cancer, lacosamide, anticonvulsant, chemotherapy-induced peripheral neuropathy, CIPN, urothelial carcinoma,
MVAC, methotrexate, vincristine, adriamycin, cisplatin
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, April 2015

Article Type
Changed
Thu, 12/15/2022 - 18:04
Display Headline
David Henry's JCSO podcast, April 2015

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry highlights two Original Reports, one on the effectiveness and safety of ipilimumab therapy in advanced melanoma, and another on the feasibility of implementing a community-based randomized trial of yoga for women who are undergoing chemotherapy for breast cancer. Also in the line-up are a Review article on sleep disorders in patients with cancer; a Community Translations examination of palonosetron and netupitant for the prevention of chemotherapy-induced nausea and vomiting in cancer patients; and Case Reports on distant skin metastases as primary presentation of gastric cancer, and sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia in a young woman. The bimonthly New Therapies feature focuses on hard-to-treat tumors, specifically, glioblastoma, bone sarcoma, and liver cancer.

References

Author and Disclosure Information

Audio / Podcast
Publications
Topics
Legacy Keywords
ipilimumab, melanoma, yoga, breast cancer, quality of life, sleep disorders, palonosetron, netupitant, NEPA, chemotherapy-induced nausea and vomiting, CINV, distant skin metastases, gastric cancer, sarcoidosis, complete heart block, warm autoimmune hemolytic anemia, glioblastoma, GBM, bevacizumab, bone sarcoma, liver cancer, nivolumab, pembrolizumab, everolimus
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry highlights two Original Reports, one on the effectiveness and safety of ipilimumab therapy in advanced melanoma, and another on the feasibility of implementing a community-based randomized trial of yoga for women who are undergoing chemotherapy for breast cancer. Also in the line-up are a Review article on sleep disorders in patients with cancer; a Community Translations examination of palonosetron and netupitant for the prevention of chemotherapy-induced nausea and vomiting in cancer patients; and Case Reports on distant skin metastases as primary presentation of gastric cancer, and sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia in a young woman. The bimonthly New Therapies feature focuses on hard-to-treat tumors, specifically, glioblastoma, bone sarcoma, and liver cancer.

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry highlights two Original Reports, one on the effectiveness and safety of ipilimumab therapy in advanced melanoma, and another on the feasibility of implementing a community-based randomized trial of yoga for women who are undergoing chemotherapy for breast cancer. Also in the line-up are a Review article on sleep disorders in patients with cancer; a Community Translations examination of palonosetron and netupitant for the prevention of chemotherapy-induced nausea and vomiting in cancer patients; and Case Reports on distant skin metastases as primary presentation of gastric cancer, and sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia in a young woman. The bimonthly New Therapies feature focuses on hard-to-treat tumors, specifically, glioblastoma, bone sarcoma, and liver cancer.

References

References

Publications
Publications
Topics
Article Type
Display Headline
David Henry's JCSO podcast, April 2015
Display Headline
David Henry's JCSO podcast, April 2015
Legacy Keywords
ipilimumab, melanoma, yoga, breast cancer, quality of life, sleep disorders, palonosetron, netupitant, NEPA, chemotherapy-induced nausea and vomiting, CINV, distant skin metastases, gastric cancer, sarcoidosis, complete heart block, warm autoimmune hemolytic anemia, glioblastoma, GBM, bevacizumab, bone sarcoma, liver cancer, nivolumab, pembrolizumab, everolimus
Legacy Keywords
ipilimumab, melanoma, yoga, breast cancer, quality of life, sleep disorders, palonosetron, netupitant, NEPA, chemotherapy-induced nausea and vomiting, CINV, distant skin metastases, gastric cancer, sarcoidosis, complete heart block, warm autoimmune hemolytic anemia, glioblastoma, GBM, bevacizumab, bone sarcoma, liver cancer, nivolumab, pembrolizumab, everolimus
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, March 2015

Article Type
Changed
Fri, 01/04/2019 - 11:10
Display Headline
David Henry's JCSO podcast, March 2015

In his March podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses two original research articles that focus on women who have survived cancer, one that looks at the effects of ArginMax on sexual functioning and quality of life in female cancer survivors, and another that examines the need for decision and communication aids among breast cancer survivors. Also included in this month’s line-up of original research is a report on the cost of palliative external beam radiotherapy for bone metastases in patients with prostate cancer and a study of the impact of an electronic medical record intervention on the use of growth factor in patients with cancer. The regular Community Translations column features the recently approved combination therapy, palbociclib plus letrozole, for first-line treatment of postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Dr Henry rounds off the podcast with a discussion the Journal Club’s entry, which this month focuses on new approvals, genetic testing, and maintenance therapy in women with ovarian cancer.

References

Author and Disclosure Information

Audio / Podcast
Publications
Legacy Keywords
ArginMax, sexual functioning, quality of life, QoL, cancer survivors, external beam radiotherapy, EBRT, palliative EBRT, bone metastases, prostate cancer, decision aids, communication aids, breast cancer survivors, electronic medical record, EMR, granulocyte colony-stimulating factors, G-CSF, palbociclib, letrozole, estrogen receptor-positive, ER-positive, human epidermal growth factor receptor 2, HER2-negative, advanced breast cancer, ovarian cancer, BRCAPRO, maintenance therapy, disease-free survival, DFS, bevacizumab, platinum-resistant ovarian cancer, pazopanib, olaparib, PARP inhibitor, AURELIA
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

In his March podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses two original research articles that focus on women who have survived cancer, one that looks at the effects of ArginMax on sexual functioning and quality of life in female cancer survivors, and another that examines the need for decision and communication aids among breast cancer survivors. Also included in this month’s line-up of original research is a report on the cost of palliative external beam radiotherapy for bone metastases in patients with prostate cancer and a study of the impact of an electronic medical record intervention on the use of growth factor in patients with cancer. The regular Community Translations column features the recently approved combination therapy, palbociclib plus letrozole, for first-line treatment of postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Dr Henry rounds off the podcast with a discussion the Journal Club’s entry, which this month focuses on new approvals, genetic testing, and maintenance therapy in women with ovarian cancer.

In his March podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses two original research articles that focus on women who have survived cancer, one that looks at the effects of ArginMax on sexual functioning and quality of life in female cancer survivors, and another that examines the need for decision and communication aids among breast cancer survivors. Also included in this month’s line-up of original research is a report on the cost of palliative external beam radiotherapy for bone metastases in patients with prostate cancer and a study of the impact of an electronic medical record intervention on the use of growth factor in patients with cancer. The regular Community Translations column features the recently approved combination therapy, palbociclib plus letrozole, for first-line treatment of postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Dr Henry rounds off the podcast with a discussion the Journal Club’s entry, which this month focuses on new approvals, genetic testing, and maintenance therapy in women with ovarian cancer.

References

References

Publications
Publications
Article Type
Display Headline
David Henry's JCSO podcast, March 2015
Display Headline
David Henry's JCSO podcast, March 2015
Legacy Keywords
ArginMax, sexual functioning, quality of life, QoL, cancer survivors, external beam radiotherapy, EBRT, palliative EBRT, bone metastases, prostate cancer, decision aids, communication aids, breast cancer survivors, electronic medical record, EMR, granulocyte colony-stimulating factors, G-CSF, palbociclib, letrozole, estrogen receptor-positive, ER-positive, human epidermal growth factor receptor 2, HER2-negative, advanced breast cancer, ovarian cancer, BRCAPRO, maintenance therapy, disease-free survival, DFS, bevacizumab, platinum-resistant ovarian cancer, pazopanib, olaparib, PARP inhibitor, AURELIA
Legacy Keywords
ArginMax, sexual functioning, quality of life, QoL, cancer survivors, external beam radiotherapy, EBRT, palliative EBRT, bone metastases, prostate cancer, decision aids, communication aids, breast cancer survivors, electronic medical record, EMR, granulocyte colony-stimulating factors, G-CSF, palbociclib, letrozole, estrogen receptor-positive, ER-positive, human epidermal growth factor receptor 2, HER2-negative, advanced breast cancer, ovarian cancer, BRCAPRO, maintenance therapy, disease-free survival, DFS, bevacizumab, platinum-resistant ovarian cancer, pazopanib, olaparib, PARP inhibitor, AURELIA
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, February 2015

Article Type
Changed
Fri, 01/04/2019 - 11:10
Display Headline
David Henry's JCSO podcast, February 2015

The line-up for David Henry’s monthly podcast for The Journal of Community and Supportive Oncology includes an Original Report in which investigators report complete response rates (no emesis, no rescue medication) APF530, a sustained-release granisetron, during the acute and delayed phases of chemotherapy-induced nausea and vomiting over multiple cycles of the therapy. He also discusses the findings from a study on joint breast and colorectal cancer screenings in medically underserved women, and another in women with self-reported lower limb lymphedema after treatment for gynecological cancers and their use of services. A fourth Original Report examines perceptions about participation in cancer clinical trials in New York state and how increased outreach and a team approach to educating and enrolling patients in trials are important to increase participation and ensure a diverse sample of participants. Finally, a feature article on new therapies looks at the significant challenges – and recent advances – in the treatment of head and neck cancers.

References

Author and Disclosure Information

Audio / Podcast
Publications
Legacy Keywords
Chemotherapy-induced nausea and vomiting, CINV, antiemetic responses, APF530, sustained-release granisetron, breast cancer screening, colorectal cancer screening, underserved women, fecal occult blood test, FOBT, mammogram, nurse support, lower-limb lymphedema, LLL, gynecological cancers, psychosocial symptoms, depression, anxiety, quality of life, clinical trials, participation in cancer trials, head and neck cancers, head and neck squamous cell carcinoma, HNSCC, epidermal growth factor receptor, EGFR, monoclonal antibody, mAb, tyrosine kinase inhibitors, TKIs, tobacco exposure, human papillomavirus, HPV, HPV-16
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

The line-up for David Henry’s monthly podcast for The Journal of Community and Supportive Oncology includes an Original Report in which investigators report complete response rates (no emesis, no rescue medication) APF530, a sustained-release granisetron, during the acute and delayed phases of chemotherapy-induced nausea and vomiting over multiple cycles of the therapy. He also discusses the findings from a study on joint breast and colorectal cancer screenings in medically underserved women, and another in women with self-reported lower limb lymphedema after treatment for gynecological cancers and their use of services. A fourth Original Report examines perceptions about participation in cancer clinical trials in New York state and how increased outreach and a team approach to educating and enrolling patients in trials are important to increase participation and ensure a diverse sample of participants. Finally, a feature article on new therapies looks at the significant challenges – and recent advances – in the treatment of head and neck cancers.

The line-up for David Henry’s monthly podcast for The Journal of Community and Supportive Oncology includes an Original Report in which investigators report complete response rates (no emesis, no rescue medication) APF530, a sustained-release granisetron, during the acute and delayed phases of chemotherapy-induced nausea and vomiting over multiple cycles of the therapy. He also discusses the findings from a study on joint breast and colorectal cancer screenings in medically underserved women, and another in women with self-reported lower limb lymphedema after treatment for gynecological cancers and their use of services. A fourth Original Report examines perceptions about participation in cancer clinical trials in New York state and how increased outreach and a team approach to educating and enrolling patients in trials are important to increase participation and ensure a diverse sample of participants. Finally, a feature article on new therapies looks at the significant challenges – and recent advances – in the treatment of head and neck cancers.

References

References

Publications
Publications
Article Type
Display Headline
David Henry's JCSO podcast, February 2015
Display Headline
David Henry's JCSO podcast, February 2015
Legacy Keywords
Chemotherapy-induced nausea and vomiting, CINV, antiemetic responses, APF530, sustained-release granisetron, breast cancer screening, colorectal cancer screening, underserved women, fecal occult blood test, FOBT, mammogram, nurse support, lower-limb lymphedema, LLL, gynecological cancers, psychosocial symptoms, depression, anxiety, quality of life, clinical trials, participation in cancer trials, head and neck cancers, head and neck squamous cell carcinoma, HNSCC, epidermal growth factor receptor, EGFR, monoclonal antibody, mAb, tyrosine kinase inhibitors, TKIs, tobacco exposure, human papillomavirus, HPV, HPV-16
Legacy Keywords
Chemotherapy-induced nausea and vomiting, CINV, antiemetic responses, APF530, sustained-release granisetron, breast cancer screening, colorectal cancer screening, underserved women, fecal occult blood test, FOBT, mammogram, nurse support, lower-limb lymphedema, LLL, gynecological cancers, psychosocial symptoms, depression, anxiety, quality of life, clinical trials, participation in cancer trials, head and neck cancers, head and neck squamous cell carcinoma, HNSCC, epidermal growth factor receptor, EGFR, monoclonal antibody, mAb, tyrosine kinase inhibitors, TKIs, tobacco exposure, human papillomavirus, HPV, HPV-16
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, January 2015

Article Type
Changed
Thu, 12/15/2022 - 18:06
Display Headline
David Henry's JCSO podcast, January 2015

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry looks at Original Reports on the comparison of atropine-diphenoxylate and hyoscyamine in lowering the rates of irinotecan-related cholinergic syndrome; the effects of age and comorbidities in the management of rectal cancer in elderly patients at an institution in Portugal; the impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer; and the beneficial effects of animal-assisted visits on quality of life during multimodal radiation-chemotherapy regimens. He also discusses a Research Report in which the authors attempt, possibly for the first time, to quantify radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer, as well as two feature articles – a round-up of some of the presentations at the 2014 San Antonio Breast Cancer Symposium and a Journal Club presentation of therapies for lymphoproliferative disorders.

References

Author and Disclosure Information

Audio / Podcast
Publications
Topics
Legacy Keywords
atropine-diphenoxylate, hyoscyamine, irinotecan, cholinergic syndrome, rectal cancer, telehealth, quality of life, QoL, symptom distress, head and neck cancer, animal-assisted visits, AAV, multimodal radiation-chemotherapy, radiation exposure, diagnostic procedures, DPs, breast cancer, immunotherapy, pembrolizumab, SOFT trial, Ovarian suppression, tamoxifen, fulvestrant, Hodgkin lymphoma, RESORT trial, chronic lymphocytic leukemia
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry looks at Original Reports on the comparison of atropine-diphenoxylate and hyoscyamine in lowering the rates of irinotecan-related cholinergic syndrome; the effects of age and comorbidities in the management of rectal cancer in elderly patients at an institution in Portugal; the impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer; and the beneficial effects of animal-assisted visits on quality of life during multimodal radiation-chemotherapy regimens. He also discusses a Research Report in which the authors attempt, possibly for the first time, to quantify radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer, as well as two feature articles – a round-up of some of the presentations at the 2014 San Antonio Breast Cancer Symposium and a Journal Club presentation of therapies for lymphoproliferative disorders.

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry looks at Original Reports on the comparison of atropine-diphenoxylate and hyoscyamine in lowering the rates of irinotecan-related cholinergic syndrome; the effects of age and comorbidities in the management of rectal cancer in elderly patients at an institution in Portugal; the impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer; and the beneficial effects of animal-assisted visits on quality of life during multimodal radiation-chemotherapy regimens. He also discusses a Research Report in which the authors attempt, possibly for the first time, to quantify radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer, as well as two feature articles – a round-up of some of the presentations at the 2014 San Antonio Breast Cancer Symposium and a Journal Club presentation of therapies for lymphoproliferative disorders.

References

References

Publications
Publications
Topics
Article Type
Display Headline
David Henry's JCSO podcast, January 2015
Display Headline
David Henry's JCSO podcast, January 2015
Legacy Keywords
atropine-diphenoxylate, hyoscyamine, irinotecan, cholinergic syndrome, rectal cancer, telehealth, quality of life, QoL, symptom distress, head and neck cancer, animal-assisted visits, AAV, multimodal radiation-chemotherapy, radiation exposure, diagnostic procedures, DPs, breast cancer, immunotherapy, pembrolizumab, SOFT trial, Ovarian suppression, tamoxifen, fulvestrant, Hodgkin lymphoma, RESORT trial, chronic lymphocytic leukemia
Legacy Keywords
atropine-diphenoxylate, hyoscyamine, irinotecan, cholinergic syndrome, rectal cancer, telehealth, quality of life, QoL, symptom distress, head and neck cancer, animal-assisted visits, AAV, multimodal radiation-chemotherapy, radiation exposure, diagnostic procedures, DPs, breast cancer, immunotherapy, pembrolizumab, SOFT trial, Ovarian suppression, tamoxifen, fulvestrant, Hodgkin lymphoma, RESORT trial, chronic lymphocytic leukemia
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, December 2014

Article Type
Changed
Fri, 01/04/2019 - 11:10
Display Headline
David Henry's JCSO podcast, December 2014

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses articles on the recent approval of ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression and the “small victories” in honing new therapies for hard-to-treat cancers such as ovarian, melanoma, and pancreatic. Quality of care and patient quality of life are the basis for the 3 Original Reports that Dr Henry addresses: one study looks at the impact of patient navigation on diagnostic resolution in women with abnormal screenings for breast or cervical cancer; a second examines how the information and communication needs of Chinese American women with breast cancer can be channeled into improving quality of life after treatment for cancer; and a third reports on how dignity therapy as an intervention in patients with advanced colorectal cancer can positively affect the quality of end-of-life care, treatment choices, and cost efficiency.

References

Author and Disclosure Information

Audio / Podcast
Publications
Legacy Keywords
ramucirumab, gastric cancer, GEJ adenocarcinoma, gastroesophageal junction adenocarcinoma, Chinese American, breast cancer, survivorship care, patient information needs, patient-provider communication, dignity therapy, colorectal cancer, quality of life, quality of care, end-of-life care, diagnostic resolution, patient navigation, ovarian cancer, melanoma, pancreatic cancer, hard-to-treat cancers, PARP inhibitors, ipilimumab, pembrolizumab, FOLFIRINOX, nab-paclitaxel, erlotinib
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses articles on the recent approval of ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression and the “small victories” in honing new therapies for hard-to-treat cancers such as ovarian, melanoma, and pancreatic. Quality of care and patient quality of life are the basis for the 3 Original Reports that Dr Henry addresses: one study looks at the impact of patient navigation on diagnostic resolution in women with abnormal screenings for breast or cervical cancer; a second examines how the information and communication needs of Chinese American women with breast cancer can be channeled into improving quality of life after treatment for cancer; and a third reports on how dignity therapy as an intervention in patients with advanced colorectal cancer can positively affect the quality of end-of-life care, treatment choices, and cost efficiency.

In his monthly podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses articles on the recent approval of ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression and the “small victories” in honing new therapies for hard-to-treat cancers such as ovarian, melanoma, and pancreatic. Quality of care and patient quality of life are the basis for the 3 Original Reports that Dr Henry addresses: one study looks at the impact of patient navigation on diagnostic resolution in women with abnormal screenings for breast or cervical cancer; a second examines how the information and communication needs of Chinese American women with breast cancer can be channeled into improving quality of life after treatment for cancer; and a third reports on how dignity therapy as an intervention in patients with advanced colorectal cancer can positively affect the quality of end-of-life care, treatment choices, and cost efficiency.

References

References

Publications
Publications
Article Type
Display Headline
David Henry's JCSO podcast, December 2014
Display Headline
David Henry's JCSO podcast, December 2014
Legacy Keywords
ramucirumab, gastric cancer, GEJ adenocarcinoma, gastroesophageal junction adenocarcinoma, Chinese American, breast cancer, survivorship care, patient information needs, patient-provider communication, dignity therapy, colorectal cancer, quality of life, quality of care, end-of-life care, diagnostic resolution, patient navigation, ovarian cancer, melanoma, pancreatic cancer, hard-to-treat cancers, PARP inhibitors, ipilimumab, pembrolizumab, FOLFIRINOX, nab-paclitaxel, erlotinib
Legacy Keywords
ramucirumab, gastric cancer, GEJ adenocarcinoma, gastroesophageal junction adenocarcinoma, Chinese American, breast cancer, survivorship care, patient information needs, patient-provider communication, dignity therapy, colorectal cancer, quality of life, quality of care, end-of-life care, diagnostic resolution, patient navigation, ovarian cancer, melanoma, pancreatic cancer, hard-to-treat cancers, PARP inhibitors, ipilimumab, pembrolizumab, FOLFIRINOX, nab-paclitaxel, erlotinib
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, November 2014

Article Type
Changed
Fri, 12/16/2022 - 12:26
Display Headline
David Henry's JCSO podcast, November 2014

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, are reports on congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia and on the impact of aprepitant on emesis control, dose intensity, and recurrence-free survival in head and neck cancer patients on cisplatin chemotherapy. Two articles focus on patient quality of life: one examines peripheral neuropathy and its impact on QoL after chemotherapy and another looks at QoL and symptoms after stereotactic body radiotherapy in early-stage lung cancer. There’s also a Case Report about a patient with superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma, a feature article on choice of anesthesia during cancer surgery and patient outcomes, and a comprehensive and informative round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements.

Publications
Topics
Legacy Keywords
congestive heart failure, induction, anthracycline-based therapy, acute promyelocytic leukemia, impact of aprepitant on emesis control, dose intensity, recurrence-free survival, head and neck cancer, cisplatin chemotherapy, patient quality of life, peripheral neuropathy, QoL, chemotherapy, stereotactic body radiotherapy, early-stage lung cancer, superior vena cava syndrome, low-grade follicular lymphoma, anesthesia, cancer surgery, patient outcomes, and ASCO 2013-2014 guideline releases
Sections

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, are reports on congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia and on the impact of aprepitant on emesis control, dose intensity, and recurrence-free survival in head and neck cancer patients on cisplatin chemotherapy. Two articles focus on patient quality of life: one examines peripheral neuropathy and its impact on QoL after chemotherapy and another looks at QoL and symptoms after stereotactic body radiotherapy in early-stage lung cancer. There’s also a Case Report about a patient with superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma, a feature article on choice of anesthesia during cancer surgery and patient outcomes, and a comprehensive and informative round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements.

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, are reports on congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia and on the impact of aprepitant on emesis control, dose intensity, and recurrence-free survival in head and neck cancer patients on cisplatin chemotherapy. Two articles focus on patient quality of life: one examines peripheral neuropathy and its impact on QoL after chemotherapy and another looks at QoL and symptoms after stereotactic body radiotherapy in early-stage lung cancer. There’s also a Case Report about a patient with superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma, a feature article on choice of anesthesia during cancer surgery and patient outcomes, and a comprehensive and informative round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements.

Publications
Publications
Topics
Article Type
Display Headline
David Henry's JCSO podcast, November 2014
Display Headline
David Henry's JCSO podcast, November 2014
Legacy Keywords
congestive heart failure, induction, anthracycline-based therapy, acute promyelocytic leukemia, impact of aprepitant on emesis control, dose intensity, recurrence-free survival, head and neck cancer, cisplatin chemotherapy, patient quality of life, peripheral neuropathy, QoL, chemotherapy, stereotactic body radiotherapy, early-stage lung cancer, superior vena cava syndrome, low-grade follicular lymphoma, anesthesia, cancer surgery, patient outcomes, and ASCO 2013-2014 guideline releases
Legacy Keywords
congestive heart failure, induction, anthracycline-based therapy, acute promyelocytic leukemia, impact of aprepitant on emesis control, dose intensity, recurrence-free survival, head and neck cancer, cisplatin chemotherapy, patient quality of life, peripheral neuropathy, QoL, chemotherapy, stereotactic body radiotherapy, early-stage lung cancer, superior vena cava syndrome, low-grade follicular lymphoma, anesthesia, cancer surgery, patient outcomes, and ASCO 2013-2014 guideline releases
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica

David Henry's JCSO podcast, October 2014

Article Type
Changed
Fri, 01/04/2019 - 11:10
Display Headline
David Henry's JCSO podcast, October 2014

In his monthly podcast for The Journal of Community and Supportive Oncology for October, David Henry examines two research articles that focus on patient-provider communication: one article looks at patient and provider concordance on symptoms and the other discusses the informational needs and the quality of life of patients after being diagnosed with metastatic breast cancer. Two other original research articles on weight change in breast cancer patients on third-generation adjuvant chemotherapy and the quality of supportive care in patients with advanced lung cancer in the Veterans Health Administration plus a Case Report about breast cancer with brain metastases in pregnancy round off the clinical portion of the line-up. A feature article details the current state of biomarker development and challenges that temper their clinical potential.

References

Author and Disclosure Information

Publications
Legacy Keywords
patient-provider communication, concordance on symptoms, informational needs, quality of life, metastatic breast cancer, weight change in breast cancer patients, third-generation adjuvant chemotherapy, quality of supportive care, advanced lung cancer, Veterans Health Administration, breast cancer, brain metastases, pregnancy, biomarkers
Sections
Author and Disclosure Information

Author and Disclosure Information

In his monthly podcast for The Journal of Community and Supportive Oncology for October, David Henry examines two research articles that focus on patient-provider communication: one article looks at patient and provider concordance on symptoms and the other discusses the informational needs and the quality of life of patients after being diagnosed with metastatic breast cancer. Two other original research articles on weight change in breast cancer patients on third-generation adjuvant chemotherapy and the quality of supportive care in patients with advanced lung cancer in the Veterans Health Administration plus a Case Report about breast cancer with brain metastases in pregnancy round off the clinical portion of the line-up. A feature article details the current state of biomarker development and challenges that temper their clinical potential.

In his monthly podcast for The Journal of Community and Supportive Oncology for October, David Henry examines two research articles that focus on patient-provider communication: one article looks at patient and provider concordance on symptoms and the other discusses the informational needs and the quality of life of patients after being diagnosed with metastatic breast cancer. Two other original research articles on weight change in breast cancer patients on third-generation adjuvant chemotherapy and the quality of supportive care in patients with advanced lung cancer in the Veterans Health Administration plus a Case Report about breast cancer with brain metastases in pregnancy round off the clinical portion of the line-up. A feature article details the current state of biomarker development and challenges that temper their clinical potential.

References

References

Publications
Publications
Article Type
Display Headline
David Henry's JCSO podcast, October 2014
Display Headline
David Henry's JCSO podcast, October 2014
Legacy Keywords
patient-provider communication, concordance on symptoms, informational needs, quality of life, metastatic breast cancer, weight change in breast cancer patients, third-generation adjuvant chemotherapy, quality of supportive care, advanced lung cancer, Veterans Health Administration, breast cancer, brain metastases, pregnancy, biomarkers
Legacy Keywords
patient-provider communication, concordance on symptoms, informational needs, quality of life, metastatic breast cancer, weight change in breast cancer patients, third-generation adjuvant chemotherapy, quality of supportive care, advanced lung cancer, Veterans Health Administration, breast cancer, brain metastases, pregnancy, biomarkers
Sections
Article Source

PURLs Copyright

Inside the Article

David Henry's JCSO podcast, September 2014

Article Type
Changed
Fri, 01/04/2019 - 11:10
Display Headline
David Henry's JCSO podcast, September 2014

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, is a report on bacteremia in adult cancer patients with apparently stable febrile neutropenia and another on practice gaps and barriers optimal care in patients with CML, ALL, or B-cell lymphomas. Also featured is a report on treatment patterns and clinical effectiveness in patients who are treated in the community setting for metastatic castrate-resistant prostate cancer after first-line docetaxel, as well as a Case Report on a patient with metastatic melanoma presenting as disseminated sporotrichosis.

References

Author and Disclosure Information

Audio / Podcast
Publications
Legacy Keywords
bacteremia, adult cancer patients, stable febrile neutropenia, optimal care, CML, ALL, B-cell lymphomas, metastatic castrate-resistant prostate cancer, first-line docetaxel, metastatic melanoma, disseminated sporotrichosis
Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, is a report on bacteremia in adult cancer patients with apparently stable febrile neutropenia and another on practice gaps and barriers optimal care in patients with CML, ALL, or B-cell lymphomas. Also featured is a report on treatment patterns and clinical effectiveness in patients who are treated in the community setting for metastatic castrate-resistant prostate cancer after first-line docetaxel, as well as a Case Report on a patient with metastatic melanoma presenting as disseminated sporotrichosis.

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, is a report on bacteremia in adult cancer patients with apparently stable febrile neutropenia and another on practice gaps and barriers optimal care in patients with CML, ALL, or B-cell lymphomas. Also featured is a report on treatment patterns and clinical effectiveness in patients who are treated in the community setting for metastatic castrate-resistant prostate cancer after first-line docetaxel, as well as a Case Report on a patient with metastatic melanoma presenting as disseminated sporotrichosis.

References

References

Publications
Publications
Article Type
Display Headline
David Henry's JCSO podcast, September 2014
Display Headline
David Henry's JCSO podcast, September 2014
Legacy Keywords
bacteremia, adult cancer patients, stable febrile neutropenia, optimal care, CML, ALL, B-cell lymphomas, metastatic castrate-resistant prostate cancer, first-line docetaxel, metastatic melanoma, disseminated sporotrichosis
Legacy Keywords
bacteremia, adult cancer patients, stable febrile neutropenia, optimal care, CML, ALL, B-cell lymphomas, metastatic castrate-resistant prostate cancer, first-line docetaxel, metastatic melanoma, disseminated sporotrichosis
Sections
Article Source

PURLs Copyright

Inside the Article